期刊文献+

罕见病的基因治疗应用与展望 被引量:7

Application and prospect of gene therapy for rare diseases
下载PDF
导出
摘要 罕见病发病率极低、但大多病情严重且好发于儿童时期,多由遗传变异所引起。因患者数少、市场需求低,罕见病药物的研发成本极高,有药可治的罕见病仅不足1%。随着基因诊断技术进步,基因治疗凭借其“一次性彻底治愈”的特点,为遗传性罕见病患者带来了希望。本文介绍罕见病的基因治疗现状,论述传统基因递送技术和以CRISPR-Cas 9为代表的基因编辑技术在罕见病中的应用及发展。 The incidence of rare diseases is extremely low,but most of them are serious and tend to occur in childhood.Mostly they are caused by genetic mutations.Due to the small number of patients and low market demand,the research and development cost of rare disease drugs is very high,and only less than 1%of rare diseases have drugs available for treatment.With the advancement of genetic diagnosis technology,gene therapy by virtue of its"one-time complete cure"feature has brought hope to patients with hereditary rare diseases.This article reviews the current status of gene therapy for rare diseases,and discusses the application and development of traditional gene delivery technologies and gene editing technologies represented by CRISPR-Cas 9 in rare diseases.
作者 桂怡婷 李强 桂永浩 GUI Yiting;LI Qiang;GUI Yonghao(Children’s Hospital of Fudan University,Shanghai 201102,China)
出处 《临床儿科杂志》 CAS CSCD 北大核心 2020年第10期794-798,共5页 Journal of Clinical Pediatrics
关键词 罕见病 基因治疗 基因递送技术 CRISPR-Cas9基因编辑技术 rare disease gene therapy gene delivery technology CRISPR-Cas 9 gene editing technology
  • 相关文献

参考文献2

二级参考文献42

共引文献36

同被引文献59

引证文献7

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部